M. Crucianelli et al. / Journal of Fluorine Chemistry 125 (2004) 573–577
575
3. Experimental
Enantiomeric major diastereomer (2R,RS)-3 analogously
20
obtained starting from iminophosphorane (R)-1 had ½a
D
3.1. General
À39.1 (c ¼ 0:9, CHCl3). HPLC analysis: tr ¼ 7:01 min.
20
D
(2R,SS)-3: Rf ¼ 0:37 (n-Hex/EtOAc 70/30); oil; ½a
1
Chemical shifts (d) are reported in parts per million (ppm)
of the applied field. Coupling constants (J) are reported
in Hertz. Me4Si was used as internal standard (dH and
dC ¼ 0:00) for 1H and 13C nuclei, while C6F6 was used
as external standard (dF ¼ À162:90) for 19F nuclei. Peak
multiplicities are abbreviated: singlet, s; doublet, d; triplet,
t; quartet, q; multiplet, m, etc. 1H NMR spectra were
recorded at 200 MHz, 13C NMR at 50.3 MHz, 19F NMR
at 235.2 MHz. Anhydrous solvents were obtained by dis-
tillation from sodium (THF) or from calcium hydride
(dichloromethane). In all other cases commercially available
reagent-grade solvents were employed without purification.
Grignard reagents were purchased from Sigma/Aldrich/
Fluka Company. Reactions performed in dry solvents were
carried out under nitrogen atmosphere. Melting points are
uncorrected and were obtained on a capillary apparatus.
Analytical thin-layer chromatography (TLC) was routinely
used to monitor reactions. Plates precoated with E. Merck
silica gel 60 F254 of 0.25 mm thickness were used. Merck
silica gel 60 (230–400 ASTM mesh) was employed for flash
chromatography (FC). Chiral HPLC analyses were carried
out using a Chiralcel OD column, n-Hex/iso-propanol 85:15,
0.8 ml minÀ1. The iminophosphorane (S)-1 was prepared
according to the literature [5].
þ117.4 (c ¼ 0:79, CHCl3). H NMR (CDCl3): d 7.56 (d,
J ¼ 8 Hz, 2H), 7.26 (d, J ¼ 8 Hz, 2H), 5.27 (s, 1H), 4.40–
4.25 (m, 2H), 2.96 (s, 1H), 2.36 (s, 3H), 1.29 (t, J ¼ 7:2 Hz,
3H). 13C NMR (CDCl3): d 164.0, 142.1, 141.4, 129.8, 125.4,
122.0 (q, J ¼ 286:21 Hz), 81.3, 71.2, 65.1, 61.9 (q,
J ¼ 32:7 Hz), 21.4, 13.8. 19F NMR (CDCl3): d À77.7 (s).
3.3. Oxidation of (2S,SS)-3: preparation of ethyl 2-{[(4-
methylphenyl)sulfonyl]amino}-2-(trifluoromethyl)-3-
butynoate (S)-4
To 6 ml of a cooled (0 8C) dichloromethane solution
of sulfinamide (2S,SS)-3 (496 mg, 1.49 mol), 444 mg
(2.23 mmol) of m-chloro-perbenzoic acid were added under
stirring. After 15 min the mixture was allowed to warm to
RT, left under stirring for 1.5 h and then quenched. The
reaction mixture was diluted with dichloromethane and
washed with a saturated aqueous solution of Na2S2O5, the
separated organic layer was then washed with, respectively,
a saturated aqueous solution of NaHCO3 and brine, then
dried over anhydrous sodium sulfate. Purification of the
crude by FC (n-Hex/EtOAc 70/30) afforded 380 mg of (S)-4
(73% yield).
(S)-4: Rf ¼ 0:55 (n-Hex/EtOAc 70/30); mp (i-Pr2O) ¼
20
D
1
74 8C; ½a þ27.8 (c ¼ 0:5, CHCl3). H NMR (CDCl3): d
3.2. Synthesis of ethyl 2-{[(4-
methylphenyl)sulfinyl]amino}-2-(trifluoromethyl)-3-
butynoates (2S,SS)- and (2R,SS)-3
7.82 (d, J ¼ 8 Hz, 2H), 7.29 (d, J ¼ 8 Hz, 2H), 5.93 (s, 1H),
4.40–4.25 (m, 2H), 2.59 (s, 1H), 2.43 (s, 3H), 1.32
(t, J ¼ 7 Hz, 3H). 13C NMR (CDCl3): d 163.4, 144.2,
137.2, 129.4, 127.9, 121.3 (q, J ¼ 287:3 Hz), 80.0, 69.9,
65.0, 61.1 (q, J ¼ 32:7 Hz), 21.6, 13.7. 19F NMR (CDCl3):
d À76.8 (s).
Neat ethyl trifluoropyruvate (111 ml, 0.83 mmol) was
added dropwise to a solution of iminophosphorane (S)-1
(313 mg, 0.75 mmol) in 1.5 ml of THF freshly distilled
from sodium. The mixture was warmed at 40 8C for 2 h;
the yellow solution containing the sulfinimine (S)-2, was
then cooled to À70 8C and a 0.5 M THF solution of ethynyl
magnesium bromide (1.66 ml, 0.83 mmol) was added
dropwise with stirring. After 15 min the reaction mixture
was quenched at À70 8C with saturated aqueous solution
of NH4Cl, extracted with ethyl acetate and dried over
anhydrous sodium sulfate. Purification of the crude by FC
(n-Hex/EtOAc from 75/25 to 70/30) afforded 173 mg of
the major diastereomer (2S,SS)-3 (Rf >) and 15 mg of
the minor (2R,SS)-3 (Rf <) (84% d.e.) with a 75% overall
3.4. Reduction of (S)-4: preparation of ethyl 20,20,20-
trifluoro-N-[(4-methylphenyl)sulfonyl]isovalinate (S)-5
and ethyl 2-{[(4-methylphenyl)sulfonyl]amino}-2-
(trifluoromethyl)-3-butenoate (S)-6
A solution of sulfonamide (S)-4 (150 mg, 0.43 mmol) in
ethyl acetate (5 ml) was stirred for 1 h at RT in the presence
of Pd/C (10%, w/w) under hydrogen atmosphere. The
solution was then filtered on a celite pad and the solvent
removed in vacuo. FC (n-Hex/EtOAc 80/20) of the crude
afforded 144 mg (94% yield) of the desired reduction pro-
duct (S)-5.
yield.
20
D
(2S,SS)-3: Rf ¼ 0:4 (n-Hex/EtOAc 70/30); oil; ½a
(S)-5: Rf ¼ 0:70 (n-Hex/EtOAc 70/30); mp (i-Pr2O) ¼
20
þ44.20 (c ¼ 2, CHCl3). 1H NMR (CDCl3): d 7.62 (d,
J ¼ 8 Hz, 2H), 7.31 (d, J ¼ 8 Hz, 2H), 5.52 (s, 1H),
4.45–4.30 (m, 2H), 2.99 (s, 1H), 2.41 (s, 3H), 1.36 (t,
J ¼ 7:2 Hz, 3H). 13C NMR (CDCl3): d 163.6, 142.1,
129.8, 125.6, 121.92 (q, J ¼ 287:7 Hz), 80.8, 71.7, 64.8,
63.0 (q, J ¼ 33:2 Hz), 21.4, 13.8. 19F NMR (CDCl3): d
À76.5 (s); HPLC analysis: tr ¼ 9:05 min.
81 8C; ½a þ13.46 (c ¼ 0:78, CHCl3). 1H NMR (CDCl3): d
D
7.68 (d, J ¼ 8 Hz, 2H), 7.20 (d, J ¼ 8 Hz, 2H), 5.84 (s, 1H),
4.25 (q, J ¼ 8 Hz, 2H), 2.52–2.40 (m, 1H), 2.34 (s, 3H),
2.15–1.95 (m, 1H), 1.23 (t, J ¼ 8 Hz, 3H), 0.89 (t, J ¼
7:2 Hz, 3H). 13C NMR (CDCl3): d 166.3, 143.3, 138.9, 129.3,
126.7, 123.2 (q, J ¼ 286:7 Hz), 69.1 (q, J ¼ 28:2 Hz), 63.9,
23.4, 21.4, 13.7, 7.8. 19F NMR (CDCl3): d À74.0 (s).